RALPH BERRY: Open Payments
NPI 1972591097 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 66 payments from 13 companies in 2025. Trend: 2023 $263 · 2024 $862 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 23 | $221 |
| Otsuka America Pharmaceutical, Inc. | 20 | $219 |
| E.R. Squibb & Sons, L.L.C. | 3 | $78 |
| Indivior Inc. | 4 | $76 |
| Teva Pharmaceuticals USA, Inc. | 4 | $64 |
| Braeburn Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Alkermes, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $26 |
Products named: SPRAVATO, REXULTI, ABILIFY ASIMTUFII, COBENFY, SUBLOCADE, UZEDY, BRIXADI, CAPLYTA.
Industry payments across NY — which companies pay providers there.
